HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congress Pushes Food Safety Pact With China As FDA Lauds European Deal

This article was originally published in The Tan Sheet

Executive Summary

FDA is touting an agreement with European authorities to assess food safety risks as crucial to public health protection. Meanwhile, key Democrats on Capitol Hill are asking federal agencies to "make it a top priority to develop a comprehensive, legally binding" memorandum of understanding on food safety with China

You may also be interested in...



China Commits To Tightening Food Safety Supervision As MOA Talks Begin

A spokesman at the Chinese embassy in Washington says China will intensify its food safety supervision as U.S. and Chinese officials in Beijing begin work on a memorandum of agreement on food and feed safety

Stirring Up Food Safety Discussions On HHS Officials’ Agenda In Beijing

Department of Health and Human Services senior officials are consulting with Chinese food and drug regulators in China to "pave the way" for discussions on developing U.S.-China agreements for increased safety of food and feed and on drugs and medical devices, according to HHS Secretary Michael Leavitt

Drug Firms Model Ensuring Import Safety; China’s Inconsistencies Worry FDA

Firms using Chinese imports to make dietary supplements and other products can look to drug firms for lessons on ensuring the safety of raw materials from China, where adherence to food and drug production regulations remains inconsistent, current and former FDA executives tell a Senate panel

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS137883

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel